ArticleDiagnostic cytopathology2026
Primary Pulmonary Epithelioid Inflammatory Myofibroblastic Sarcoma With SQSTM1::ALK Fusion.
Article in Diagnostic cytopathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epithelioid inflammatory myofibroblastic sarcoma (EIMS) is a rare and aggressive variant of inflammatory myofibroblastic tumor (IMT) characterized by epithelioid morphology, atypical features, ALK rearrangements, and early metastatic potential. Primary pulmonary EIMS is exceptionally uncommon, and diagnosis on cytologic specimens can be challenging. A 58-year-old woman presented with cough and shortness of breath and was found to have a right lung mass. Transbronchial needle aspiration revealed scattered spindle cells in a lymphoplasmacytic background on the smears. Cell block sections demonstrated mainly spindle to few epithelioid cells with focal necrosis. Immunohistochemistry showed diffuse ALK positivity with focal SMA and desmin expression. The lesion was diagnosed as a spindle cell neoplasm concerning for an IMT with possible malignant transformation. Subsequent lobectomy revealed epithelioid morphology, marked atypia, increased mitotic activity, and extensive necrosis, establishing the diagnosis of EIMS. Molecular testing identified an SQSTM1::ALK fusion and a TERT promoter mutation. The patient developed metastatic disease and showed a limited response to ALK inhibitor therapy. This case highlights the diagnostic challenges of EIMS on cytology and underscores the importance of integrating cytomorphology, immunohistochemistry, and molecular testing for accurate diagnosis and management. It also expands the molecular spectrum of EIMS by demonstrating a rare SQSTM1::ALK fusion in a primary pulmonary tumor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.